ViatrisHAM:VIA +1.79%60 Days Inventory is 152.26 as of Mar. 2026, which is 9% above its 10-year median of 140.10. GuruFocus rates HAM:VIA with a GF Score™ of 60/100 and a GF Value™ of €9.55 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 918 Drug Manufacturers companies, Viatris ranks better than 53.59% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Viatris's Average Total Inventories for the
three
months ended in Mar. 2026 was €3,406 Mil. Viatris's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €2,041 Mil.
Hence, Viatris's Days Inventory for the
three
months ended in Mar. 2026 was 152.26.
The historical rank and industry rank for Viatris's Days Inventory or its related term are showing as below:
HAM:VIA'
s Days Inventory Range Over the Past 10 Years
Min: 125.79 Med: 140.1 Max: 182.35
Current: 155.87
During the past 13 years, Viatris's highest Days Inventory was 182.35. The lowest was 125.79. And the median was 140.10.
HAM:VIA's Days Inventory is ranked better than 53.59% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs HAM:VIA: 155.87
Viatris's Days Inventory
declined
from Mar. 2025 (176.03) to Mar. 2026 (152.26).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Viatris's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.60.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Viatris's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.12.
Viatris (HAM:VIA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Viatris's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Viatris's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Viatris Days Inventory Related Terms
Viatris Days Inventory Historical Data
* Premium members only.
The historical data trend for Viatris's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:VIA vs NBIX, UTHR, ELAN: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viatris Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viatris's Days Inventory distribution charts can be found below:
* The bar in red indicates where Viatris's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viatris (HAM:VIA) has a Days Inventory of 152.26 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Viatris and its competitors. This is near median its historical median of 140.10. Over the past decade, Viatris' Days Inventory has ranged from 125.79 to 182.35. According to the industry distribution chart, Viatris ranks #426 out of 918 companies in the Drug Manufacturers industry, placing it in the top 46.4%.
Is Viatris' Days Inventory too high?
Viatris' current Days Inventory of 152.26 is near median its 10-year median of 140.10. Over the past 10 years, this metric has ranged from a low of 125.79 to a high of 182.35. The Drug Manufacturers industry median Days Inventory is 164.43. Viatris' value of 152.26 is 7.4% below this industry median. Based on the distribution chart, Viatris ranks #426 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Viatris has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viatris' Days Inventory compare to NBIX and UTHR?
According to the Drug Manufacturers industry distribution chart, Viatris ranks #426 out of 918 companies for Days Inventory. This puts Viatris in the upper half of its industry. The industry median Days Inventory is 164.43. Viatris' value of 152.26 is 7.4% below this benchmark. Historically, Viatris' own Days Inventory has ranged from 125.79 to 182.35 over the past decade. While the company's 10-year median is 140.10 vs. the industry median of 164.43, Viatris has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viatris's current Days Inventory of 152.26 is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Viatris and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viatris's current Days Inventory is 152.26, which is near median its own 10-year median of 140.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viatris stock overvalued right now?
Based on GuruFocus' analysis, Viatris (HAM:VIA) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.55, compared to a current price of €14.27 — trading 49.4% above its estimated fair value. The current Days Inventory is 152.26, which is near median its 10-year median of 140.10 and 7.4% below the Drug Manufacturers industry median of 164.43. Viatris' overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Viatris (HAM:VIA), the current Days Inventory is 152.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viatris (HAM:VIA) Overvalued in 2026?
Based on GuruFocus' analysis, Viatris stock appears to be overvalued.
The current stock price of €14.27 is trading 49.4% above its estimated GF Value™ of €9.55.
GuruFocus considers Viatris to be Significantly Overvalued.
Key valuation signals for HAM:VIA:
Days Inventory: 152.26 (near median its 10-year median of 140.10)
GF Value™: €9.55 vs. price of €14.27 (49.4% above fair value)
Industry Position: 7.4% below the Drug Manufacturers median (#426 of 918)
No single metric tells the full story. See the HAM:VIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
60GF Score
Get the complete analysis for HAM:VIA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:VIA has been successfully added to your 
